Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Hema Dave

Showing results (1-10 of 24) with videos related to

Pageof 3
Sort By:
Cytotherapy|July 20, 2019
T-cell therapies for T-cell lymphomaKeri Toner, Catherine M Bollard, Hema Dave
Frontiers in Oncology|July 13, 2013
Immunotherapy for pediatric leukemiaNirali N Shah, Hema Dave, Alan S Wayne
Pediatric Hematology and Oncology|August 24, 2019
ROR1 and ROR2-novel targets for neuroblastomaHema Dave, Donna Butcher, Miriam Anver, et al.
Pediatric Hematology and Oncology|July 18, 2019
Iatrogenic immunodeficiency-associated lymphoproliferative disorder in a child with B-cell acute lymphoblastic leukemiaSanam Shahid, Christopher Rossi, Pranav Vyas, et al.
Stem Cell Investigation|June 14, 2017
Engineering cord blood to improve engraftment after cord blood transplantRohtesh S Mehta, Hema Dave, Catherine M Bollard, et al.
Current Hematologic Malignancy Reports|October 24, 2019
Driving the CAR to the Bone Marrow Transplant ProgramHema Dave, Lauren Jerkins, Patrick J Hanley, et al.
Cytotherapy|October 29, 2021
Alignment of practices for data harmonization across multi-center cell therapy trials: a report from the Consortium for Pediatric Cellular ImmunotherapyHisham Abdel-Azim, Hema Dave, Kimberly Jordan, et al.
Molecular Therapy. Methods & Clinical Development|November 3, 2021
Novel TCR-like CAR-T cells targeting an HLA∗0201-restricted SSX2 epitope display strong activity against acute myeloid leukemiaScott Raskin, Stacey Van Pelt, Keri Toner, et al.
Journal of Computer Assisted Tomography|December 5, 2014
The role of screening sinus computed tomography in pediatric hematopoietic stem cell transplant patientsCarlos A Zamora, Avi G Oppenheimer, Hema Dave, et al.
Urology|February 13, 2026
Treatment Selection for Non-Muscle-Invasive Bladder Cancer in an Emerging Treatment Era: A Patient Preference StudyAngela B Smith, John L Gore, Stephanie Chisolm, et al.
Pageof 3

Showing results (1-10 of 24) with videos related to

Sort By:
Pageof 3
Cytotherapy|July 20, 2019
T-cell therapies for T-cell lymphomaKeri Toner, Catherine M Bollard, Hema Dave
Frontiers in Oncology|July 13, 2013
Immunotherapy for pediatric leukemiaNirali N Shah, Hema Dave, Alan S Wayne
Pediatric Hematology and Oncology|August 24, 2019
ROR1 and ROR2-novel targets for neuroblastomaHema Dave, Donna Butcher, Miriam Anver, et al.
Pediatric Hematology and Oncology|July 18, 2019
Iatrogenic immunodeficiency-associated lymphoproliferative disorder in a child with B-cell acute lymphoblastic leukemiaSanam Shahid, Christopher Rossi, Pranav Vyas, et al.
Stem Cell Investigation|June 14, 2017
Engineering cord blood to improve engraftment after cord blood transplantRohtesh S Mehta, Hema Dave, Catherine M Bollard, et al.
Current Hematologic Malignancy Reports|October 24, 2019
Driving the CAR to the Bone Marrow Transplant ProgramHema Dave, Lauren Jerkins, Patrick J Hanley, et al.
Cytotherapy|October 29, 2021
Alignment of practices for data harmonization across multi-center cell therapy trials: a report from the Consortium for Pediatric Cellular ImmunotherapyHisham Abdel-Azim, Hema Dave, Kimberly Jordan, et al.
Molecular Therapy. Methods & Clinical Development|November 3, 2021
Novel TCR-like CAR-T cells targeting an HLA∗0201-restricted SSX2 epitope display strong activity against acute myeloid leukemiaScott Raskin, Stacey Van Pelt, Keri Toner, et al.
Journal of Computer Assisted Tomography|December 5, 2014
The role of screening sinus computed tomography in pediatric hematopoietic stem cell transplant patientsCarlos A Zamora, Avi G Oppenheimer, Hema Dave, et al.
Urology|February 13, 2026
Treatment Selection for Non-Muscle-Invasive Bladder Cancer in an Emerging Treatment Era: A Patient Preference StudyAngela B Smith, John L Gore, Stephanie Chisolm, et al.
Pageof 3